attana - sensor technologies

A New Generation of Cell-Biosensors

The article, A New Generation of Cell-Biosensors, in Innovations in Pharmaceutical Technology describes how the Attana Cell 200 biosensor has been a powerful tool in the research at University of Westminster.
 
University of Westminster focus increasingly on the definition of the metastatic breast and colorectal cancer phenotype in a move towards more targeted therapies providing a degree of personalization of healthcare.
 
The Attana Cell 200 biosensor enables molecular interactions to be studied in a more relevant cellular environment and, as a model for understanding drug-cell interactions, provides a new biological approach for targeting cell surfaces in a wide range of diseases, including cancer.
 
Read the full article in Innovations in Pharmaceutical Technology, (Issue 40), here, published in April 2012.